Skip to content

A diagnostic panel for common psychiatric disorders: a cohort study based on serum protein levels

A diagnostic panel for common psychiatric disorders: a cohort study based on serum protein levels

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DOC-16010081
Enrollment
Unknown
Registered
2016-12-05
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mental disorders (include schizophrenia, major depressive disorder, bipolar mania, bipolar depression and panic disorder )

Interventions

Index test:
Gold Standard:

Sponsors

Department of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients: (1) inpatients or outpatients; (2) Aged 16 to 60 years old; (3) met the diagnostic criteria of DSM-IV24 with schizophrenia paranoid type, major depressive disorder, bipolar I disorder, manic episode, bipolar I disorder, depressed episode and panic disorder, respectively; (4) participants sign the informed consent form. Health controls: (1) age, gender and education matched healthy individuls; (2) no organic brain disorders and heart, liver, kidney abnormality; (3) no history of mental disorders, alcohol and drug dependence.

Exclusion criteria

Exclusion criteria: Patients: (1) pregnancy or the puerperium; (2) younger than 16 years or older than 60 years; (3) secondary mental disorders, such as mental disorders that occurred on the basis of the use of certain drugs or in patients with organic brain disease or severe physical illness; (4) current incidents of alcohol or drug abuse and dependence, or any other primary neurological illness, including dementia or stroke; (5) serious cardiac, pulmonary, hepatic or renal diseases or any type of tumor.

Design outcomes

Primary

MeasureTime frame
brain-derived neurotrophic factor;tissue plasminogen activator;plasminogen activatorinhibitor-1;precursor brain-derived neurotrophic factor;tropomyosin-related kinase B;neurotrophin receptor p75;VGF;Bicaudal C homologue 1;TLQP62;

Countries

China

Contacts

Public ContactYuan Yonggui

Department of Psychosomatics and Psychiatry, Zhongda Hospital, School of Medicine, Southeast University

yygylh2000@sina.com+86 13913939082

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026